CYPH Soars 57% After EPS Estimate Triples to 254.6%
CYPH led with a 57.0% surge after its next-year EPS growth estimate jumped from 82.3% to 254.6% on August 19. MSTR rallied 32.5% following a $2 billion capital raise that expanded its bitcoin-buying firepower, while DEFT, TNON, and IDAI logged gains between 22.9% and 31.9% as their own EPS revisions and catalysts aligned.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| CYPH | Healthcare | 2026-08-19 | +172.2pp | +57.0% |
| MSTR | Technology | 2026-08-18 | +5.9pp | +32.5% |
| DEFT | Financial | 2026-08-17 | N/A | +31.9% |
| TNON | Healthcare | 2026-08-17 | +21.0pp | +28.2% |
| IDAI | Technology | 2026-08-18 | +7.5pp | +22.9% |
Why did CYPH stock jump in August 2026?
CYPH jumped 57.0% (from $1.07 to $1.68) after its next-year EPS growth estimate soared to 254.6% on August 19, up from 82.3%.
The 172.2 percentage-point revision — among the largest the screener has flagged this month — caught the stock before the move, and no earnings-specific news followed, pointing to a pure estimates-driven repricing. In healthcare, where momentum often lags small-cap pharma, CYPH's revision likely stemmed from a pipeline or revenue upgrade that investors began to price in. The stock's gain underscores how quickly the market reacts when revisions cross triple-digit thresholds.
CYPH EPS revision history → · Screener snapshot from 2026-08-19 →
FAQ: CYPH
Why did CYPH stock jump in August 2026?
CYPH jumped 57.0% from $1.07 to $1.68 after its next-year EPS growth estimate was revised from 82.3% to 254.6% on August 19.
Is CYPH a buy after the rally?
The 254.6% EPS growth estimate signals strong expected earnings acceleration, but with no earnings news to confirm, investors should weigh the revision's sustainability against price momentum.
What is CYPH's EPS growth estimate?
CYPH's next-year EPS growth estimate stands at 254.6%, up sharply from 82.3% before the August 19 revision.
Why did MSTR stock jump in August 2026?
MSTR jumped 32.5% (from $92.52 to $122.63) after its next-year EPS revision moved from 135.4% to 141.3% on August 18, with news of a $2B capital raise reinforcing the move.
On August 24, Strategy completed a $2.01 billion at-the-market offering of 18.26 million shares, raising its USD Reserve to $5.10 billion and adding a $1.59 billion USD Cash pool earmarked for bitcoin purchases or buybacks. The company left its 840,447 BTC holdings untouched, preserving its bitcoin exposure while boosting liquidity to $6.69 billion. The market rewarded the dry powder for future bitcoin accumulation, a positive catalyst for the revision-driven rally.
MSTR EPS revision history → · Screener snapshot from 2026-08-18 →
FAQ: MSTR
Why did MSTR stock jump in August 2026?
MSTR jumped 32.5% from $92.52 to $122.63 after its EPS growth estimate rose to 141.3% and the company raised $2 billion cash without selling bitcoin.
What caused MSTR's surge?
The surge followed a $2.01 billion equity raise that added $1.59 billion in dry powder for bitcoin buys or buybacks, while the EPS revision to 141.3% supported earnings momentum.
What is MSTR's EPS growth estimate?
MSTR's next-year EPS growth estimate is 141.3%, up from 135.4% after the August 18 revision.
Why did DEFT stock jump in August 2026?
DEFT jumped 31.9% (from $0.47 to $0.62) after its next-year EPS growth estimate came in at 1550.2%, detected on August 17.
The move was reinforced by Q2 2026 results on August 20 showing $22.8 million in Valour net inflows and a $1.6 million cut in operating expenses, despite total revenue declining to $7.8 million from $11.2 million. The EPS figure—driven by cost control and product demand—caught the market's attention, lifting the stock even as AUM fell to $397.2 million. DEFT's rally underscores how revision screens can flag names ahead of fundamentals repricing.
DEFT EPS revision history → · Screener snapshot from 2026-08-17 →
FAQ: DEFT
Why did DEFT stock jump in August 2026?
DEFT climbed 31.9% from $0.47 to $0.62 after its EPS growth estimate hit 1550.2%, with Q2 results showing $22.8 million in inflows and reduced costs.
What is DEFT's EPS growth estimate?
DEFT's next-year EPS growth estimate is 1550.2%, reflecting expectations of dramatic earnings expansion.
What caused DEFT's surge?
The surge was driven by the massive EPS revision combined with Q2 net inflows of $22.8 million and a 16.7% cut in operating expenses.
Why did TNON stock jump in August 2026?
TNON jumped 28.2% (from $4.92 to $6.31) after its next-year EPS growth estimate rose from 28.4% to 49.4% on August 17, a 21.0 percentage-point increase.
No earnings-related news followed, so the gain was purely revision-driven as investors repositioned around the improved outlook. In healthcare, early-stage revisions often precede clinical or commercial milestones, and TNON's move suggests the market saw the estimate bump as a leading indicator. The stock's absence of fresh news highlights how powerful a single upward EPS revision can be for small-cap names.
TNON EPS revision history → · Screener snapshot from 2026-08-17 →
FAQ: TNON
Why did TNON stock jump in August 2026?
TNON jumped 28.2% from $4.92 to $6.31 after its EPS growth estimate was revised up to 49.4% from 28.4% on August 17.
What caused TNON's surge?
The surge was driven entirely by the 21.0 percentage-point upward EPS revision, with no earnings news in the window.
What is TNON's EPS growth estimate?
TNON's next-year EPS growth estimate now stands at 49.4%, up from 28.4% prior to the revision.
Why did IDAI stock jump in August 2026?
IDAI jumped 22.9% (from $2.49 to $3.06) after its next-year EPS growth estimate increased to 111.7% from 104.2% on August 18.
The 7.5 percentage-point revision, while smaller than peers, pushed the stock above the triple-digit threshold that often triggers algorithmic buying. In technology, where IDAI operates in identity verification, no earnings news followed, so the move likely reflected broader sector momentum and the revision's signal. The stock's gain shows that even modest revisions can produce outsized moves when tied to high-growth estimates.
IDAI EPS revision history → · Screener snapshot from 2026-08-18 →
FAQ: IDAI
Why did IDAI stock jump in August 2026?
IDAI jumped 22.9% from $2.49 to $3.06 after its EPS growth estimate rose to 111.7% from 104.2% on August 18.
What is IDAI's EPS growth estimate?
IDAI's next-year EPS growth estimate is 111.7%, reflecting strong expected earnings acceleration.
What caused IDAI's surge?
The surge was driven by the upward EPS revision to 111.7%, with no earnings news in the window, suggesting market repricing on estimate strength.
Today's performers show that upward EPS revisions—even modest ones—can catalyze double-digit gains when estimates cross key thresholds. The mix of healthcare, tech, and financial names suggests investors are hunting for earnings acceleration across sectors, rewarding companies with clear catalysts like MSTR's capital raise or pure revision signals like CYPH.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →